Results 1 to 1 of 1
  1. #1
    Deal GURU
    Join Date
    Aug 2008
    Posts
    5,321
    Downloads
    0
    Uploads
    0

    Info FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market

    Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of the product from the U.S. market. The company is taking this action because of a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML), a rare, serious, progressive neurologic disease caused by a virus that affects the central nervous system. By June 8, 2009, Raptiva will no longer be available in the United States.

    Read More...

  2. The Following User Says Thank You to budget For This Useful Post:


 

 

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •